Literature DB >> 7004139

In vitro methods to predict for patient response to chemotherapy.

D D Von Hoff, L Weisenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7004139     DOI： 10.1016/s1054-3589(08)60009-5

Source DB:  PubMed          Journal:  Adv Pharmacol Chemother        ISSN： 0065-3144


× No keyword cloud information.
  9 in total

1.  Chemosensitivity study of urological malignancies using a novel dye-exclusion method.

Authors:  K Naito; H Hisazumi; S Mihara; T Asari; K Kobashi; T Amano; T Uchibayashi
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting.

Authors:  B Rotman; C Teplitz; K Dickinson; J P Cozzolino
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

Review 3.  Predictive testing in cancer chemotherapy. II. In vitro.

Authors:  P H Slee; A T Van Oosterom; E A De Bruijn
Journal:  Pharm Weekbl Sci       Date:  1985-08-23

Review 4.  Prediction of response to drug therapy of cancer. A review of in vitro assays.

Authors:  W T Bellamy
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 5.  Experimental systems for analysis of the malignant phenotype.

Authors:  G Poste
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 6.  Prediction of response to cancer chemotherapy.

Authors:  M F Sarosdy; D D Von Hoff
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

7.  Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.

Authors:  M D Shelley; R G Fish; M Adams; I Kerby
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

8.  An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.

Authors:  A G Bosanquet; M C Bird; W J Price; E D Gilby
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

9.  Clinical correlates of in vitro drug sensitivities of ovarian cancer cells.

Authors:  L Morasca; E Erba; M Vaghi; C Ghelardoni; C Mangioni; C Sessa; F Landoni; S Garattini
Journal:  Br J Cancer       Date:  1983-07       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.